Can the addition of bevacizumab to IFL chemotherapy improve outcome in colorectal cancer?

被引：0
|
作者：
Eric Van Cutsem
机构：
[1] Professor of Medicine and Head of the Digestive Oncology Unit at the University Hospital Gasthuisberg,
来源：
Nature Clinical Practice Gastroenterology & Hepatology | 2004年 / 1卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：72 / 73
页数：1
相关论文
共 50 条
  • [41] Efficacy of bevacizumab plus bolus irinotecan, fluorouracil and leucovorin (IFL-BV) for highly pretreated metastatic colorectal cancer (MCRC)
    Carrera, S.
    Munoz, A.
    Gil-Negrete, A.
    Rubio, I
    Ancizar, N.
    Calvo, B.
    Fuente, N.
    Barcelo, R.
    Janhi, M.
    Lopez-Vivanco, G.
    ANNALS OF ONCOLOGY, 2006, 17 : 68 - 68
  • [42] Chemotherapy for advanced colorectal cancer - It can improve quality of care and offer modest increases in survival
    Michael, M
    Zalcberg, JR
    BMJ-BRITISH MEDICAL JOURNAL, 2000, 321 (7260): : 521 - 522
  • [43] Can we individualise chemotherapy for colorectal cancer?
    Chan, R
    Kerr, DJ
    ANNALS OF ONCOLOGY, 2004, 15 (07) : 996 - 999
  • [44] A Randomized Phase-IIIb Trial of Chemotherapy, Bevacizumab, and Panitumumab Compared with Chemotherapy and Bevacizumab Alone for Metastatic Colorectal Cancer
    Mross, Klaus
    STRAHLENTHERAPIE UND ONKOLOGIE, 2009, 185 (09) : 617 - 618
  • [45] Preoperative radiotherapy for rectal cancer: Does the addition of concurrent 5 FU chemotherapy improve response and outcome
    Myerson, RJ
    Malyapa, R
    Birnbaum, E
    Dietz, D
    Fleshman, J
    Kodner, I
    Lamoreaux, W
    Lowney, J
    Mutch, M
    Picus, J
    Ratkin, G
    B, T
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 60 (01): : S297 - S298
  • [46] UTILIZATION OF BEVACIZUMAB AMONG MEDICARE PATIENTS WITH COLORECTAL CANCER RECEIVING CHEMOTHERAPY
    Fu, A. Z.
    Tsai, H. T.
    Potosky, A. L.
    VALUE IN HEALTH, 2013, 16 (03) : A151 - A151
  • [47] CHEMOTHERAPY WITH OR WITHOUT BEVACIZUMAB IN ADVANCED COLORECTAL CANCER: A PHASE III TRIAL
    Stathopoulos, G. P.
    Batziou, C.
    Trafalis, D.
    Koutantos, J.
    Batzios, S.
    Stathopoulos, J.
    Legakis, J.
    Armacolas, A.
    ANNALS OF ONCOLOGY, 2010, 21 : 196 - 196
  • [48] Neoadjuvant chemotherapy including bevacizumab in potentially curable metastatic colorectal cancer
    Gruenberger, B.
    Scheithauer, W.
    Tamandl, D.
    Puhalla, H.
    Kornek, G.
    Zielinski, C.
    Gruenberger, T.
    ANNALS OF ONCOLOGY, 2006, 17 : 39 - 40
  • [49] Bevacizumab combined with chemotherapy for patients with advanced colorectal cancer: a systematic review
    Welch, S.
    Spithoff, K.
    Rumble, R. B.
    Maroun, J.
    ANNALS OF ONCOLOGY, 2010, 21 (06) : 1152 - 1162
  • [50] Interstitial pneumonia during bevacizumab-based chemotherapy for colorectal cancer
    Tamura, Shingo
    Kusaba, Hitoshi
    Kubo, Naoki
    Ijichi, Kayo
    Tsuchihashi, Kenji
    Komoda, Masato
    Uchino, Keita
    Ariyama, Hiroshi
    Akashi, Koichi
    Baba, Eishi
    MEDICAL ONCOLOGY, 2014, 31 (03)
12345